Form 4: Colgate-Palmolive Director Acquires Stock

John P. Bilbrey, a Director at Colgate-Palmolive, acquired company stock through a deferred compensation plan.

Summary

• Director John P. Bilbrey acquired 266 shares of Colgate-Palmolive common stock on April 1, 2026.
• The acquisition was made at a price of $89.05 per share.
• These shares represent a portion of his annual cash retainer deferred into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors.
• Following this transaction, Mr. Bilbrey beneficially owns 37,665 shares of common stock, with 4,719 shares held indirectly by a trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine compensation-related stock acquisition by a director rather than a significant new investment or divestment.

Positives

• Director ownership of company stock can signal confidence in the company's future prospects.
• The acquisition was made through a deferred compensation plan, indicating a long-term commitment rather than an open market purchase.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, particularly through deferred compensation plans, are common among directors in the consumer staples sector as a way to align executive interests with shareholder value over the long term.

Corporate Governance

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of confidence in the company's future performance.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Keywords

Colgate-Palmolive, Form 4, Insider Trading, Director Compensation, Stock Acquisition, Deferred Compensation